NCT06392841 2025-10-20
HARMONY
Hoosier Cancer Research Network
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT06527690 2025-09-29
REPRESENTATION
Latin American Cooperative Oncology Group
Phase 2 Withdrawn
NCT06365970 2025-02-03
Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
University of Pittsburgh
Phase 2 Withdrawn
NCT05174455 2023-09-18
Niraparib for the Treatment of Leiomyosarcoma
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT05412706 2023-09-08
Bohème
Ospedale Policlinico San Martino
Phase 2 Withdrawn
NCT04895046 2022-06-29
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
Hoosier Cancer Research Network
Phase 2 Withdrawn